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Background
Unintended pregnancy remains a signif-
icant public health challenge in the 21st 
century. Up to 50% of all pregnancies are 
thought to be unintended at conception. 
Due to the rapid return of fertility and 
sexual activity, the postpartum period is 
high- risk for unintended pregnancy, and 
the need for effective contraception at this 
time has long been underestimated.
A short interpregnancy interval (defined 
as less than 12 months between childbirth 
and subsequent conception) is an inde-
pendent risk factor for preterm birth, fetal 
growth restriction and stillbirth.1 Further-
more, many unintended pregnancies at 
this time will end in abortion, with an esti-
mated one in thirteen women attending 
an abortion clinic in the UK within a year 
of giving birth.2
One of the key strategies to reduce 
unintended pregnancy and abortion at 
this time is already within our clinical 
armoury: long- acting reversible contra-
ception (LARC). LARC is safe for use by 
most women, including during the imme-
diate postpartum period and while breast-
feeding.3 LARC methods are also the most 
effective at preventing unintended preg-
nancy and are highly cost effective. Initi-
ating LARC immediately postpartum has 
also been shown to significantly reduce 
the risk of a short interpregnancy interval. 
But for a new mother, LARC can be the 
most challenging method to access.
After leaving the delivery suite, contra-
ception is not usually a priority for 
women as looking after the newborn and 
recovering from childbirth predominate. 
But delaying this discussion until a post-
natal check 6 weeks later with a general 
practitioner (GP) is also less than ideal. 
Increasing GP workloads and limited 
consultation times means that a full 
discussion and initiation of contraception 
can be challenging, especially for LARC 
methods which often require additional 
appointments to start.4 Given that at least 
50% of couples will have resumed sexual 
activity by 6 weeks’ postpartum, these 
barriers may further delay or discourage 
access to highly effective contraception at 
a time when there is a risk of unintended 
pregnancy.
Increasing emphasis is therefore being 
placed on maternity services, with the 
support of their community colleagues, to 
provide contraception immediately post-
partum. However, developing the clin-
ical infrastructure, training and resources 
required to achieve this can be complex. 
Despite these difficulties, there are many 
encouraging examples of this in current 
UK practice, and here I will consider the 
experience of NHS Lothian (Edinburgh. 
Scotland) to highlight some of these.
antenatal contraceptive 
counselling
A busy postnatal ward may not be an ideal 
setting in which to introduce contracep-
tive discussion for the first time and is 
not the preference of women or staff.5 
In contrast, the antenatal period is a time 
when women are often in contact with 
many different healthcare providers, 
offering multiple opportunities to discuss 
contraception, and adequate time for 
women to consider their options more 
fully.
A pilot project in Lothian in 2014 
showed that it was feasible to implement 
antenatal counselling by community 
midwives, and that this was acceptable to 
both women and staff.6 Following this, 
all pregnant women in the region are 
now offered contraceptive counselling 
at around the 20- week antenatal visit as 
part of the routine pregnancy pathway. 
Advance decision- making regarding post-
natal contraception can help to facilitate 
more timely provision after childbirth.
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Most of the current UK public health strategies 
now recommend the integration of contraceptive 
discussion into routine antenatal care. However, to 
ensure women’s postpartum contraceptive choices can 
supported, this needs to be coupled with access to a 
range of methods.
enhanced provision of postpartum 
methods
The Faculty of Sexual & Reproductive Healthcare 
(FSRH) Contraception After Pregnancy guideline 
supports the initiation of most methods of contracep-
tion immediately postpartum (with the exception of 
combined hormonal methods).3 While oral contracep-
tives and injectables can be relatively easily stocked 
on a postnatal ward, the challenge in offering LARC 
is that these methods require trained providers to fit 
them. Furthermore, these providers need to be present 
in sufficient number to achieve ‘round the clock’ 
provision within the unique clinical context of labour 
and delivery.
This can be accomplished by training both midwives 
and obstetric doctors to insert implants in the mater-
nity setting, which has been successful in Lothian 
through the development of a tailored training 
package. Notably, the FSRH has recently introduced 
an insertion- only Letter of Competence to meet the 
specific training needs of these providers. Locally there 
have also been successful programmes of postpartum 
implant insertion at home by community midwives 
for particularly vulnerable groups of women,7 further 
extending access to postpartum LARC.
However, women’s contraceptive choices immedi-
ately postpartum have generally failed to include intra-
uterine contraception (IUC). This is usually delayed 
until 4 or 6 weeks’ postpartum (interval insertion), 
despite current FSRH recommendations supporting 
insertion within 48 hours.3 It also known that only 
around 50% of women attend for interval postpartum 
insertion, even when these appointments are made at 
the time of delivery.2 Therefore, the logical approach 
is to provide postpartum intrauterine contraception 
(PPIUC) insertion at the time of childbirth.
immediate postpartum intrauterine 
contraception
The concept of PPIUC is not new: it has been offered in 
numerous low- and middle- income settings for many 
years and there is now a wealth of evidence to support 
its safety.8 The device can be inserted via the uterine 
incision at caesarean section (either manually or using 
an instrument) or at vaginal birth using specialised 
(Kelly) forceps to achieve adequate fundal placement 
within the enlarged postpartum uterus.
Intra- caesarean IUC insertion was introduced to 
the Lothian region in 2015, and around one in seven 
women having an elective caesarean section now 
choose this option. Previously published outcomes 
demonstrated a low rate of complications with this 
procedure, and almost three out of four women 
have continued IUC use at 12 months’ postpartum.9 
Notably, there is a higher likelihood of non- visible 
threads at 6 weeks’ postpartum, necessitating the need 
for formal follow- up examination (and access to ultra-
sound if required).
Intra- caesarean provision is a positive step towards 
extending the availability of LARC at the time of child-
birth. However, as the majority of women will experi-
ence a vaginal birth, they should not be disadvantaged 
in their ability to access PPIUC. The vaginal PPIUC 
insertion technique is one with which many UK clini-
cians are unfamiliar, and this can lead to uncertainty 
and reluctance to provide it. There is also limited 
evidence about how to implement this complex health 
intervention in practical terms.
In an attempt to further knowledge in this area and 
investigate vaginal PPIUC provision in a ‘real world’ 
context, we established a health service evaluation 
study in Lothian in 2017. Obstetric doctors and labour 
ward midwives were trained to insert vaginal PPIUC, 
and eligible women could choose to access this service 
following antenatal discussion with their community 
midwife. Over 400 women to date have received 
PPIUC insertion at vaginal birth, with our published 
findings expected early next year.
One of the often- cited limitations of vaginal PPIUC 
provision is the higher rate of device expulsion. The 
actual reported rate varies considerably between 
studies, from as low as 4% to over 30%,8 with lower 
rates observed among highly experienced inserters.
Within the catalogue of postpartum LARC, imme-
diate IUC insertion remains the most difficult to access 
in the UK as PPIUC services are not widely available. 
Although there is a growing interest among clinicians 
to provide this, routine implementation is not without 
its challenges and there is an important need for ‘early 
adopters’ to share their experience and knowledge in 
order to progress this further.10
supporting the ‘life course’ approach to 
women’s health
The antenatal period presents a unique transitional 
time with the opportunity to address women’s future 
health and reproductive needs, alongside those directly 
related to the current pregnancy. Postpartum contra-
ception has an important role in reducing the risk of an 
unintended pregnancy in the months after childbirth, 
as well as supporting women and couples to optimally 
plan and space their future pregnancies.
As healthcare professionals we can encourage this 
by providing opportunities to discuss future fertility 
intentions and by facilitating easier access to a range 
of contraceptive options and the most effective LARC 
methods, including in non- traditional settings such as 
the labour ward. By doing so we can remove some of 
the barriers that currently exist for women accessing 
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contraception at this time, and achieve truly holistic 
care of women during pregnancy, childbirth and 
beyond.
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